Physician profile
Mohit K Turagam
NPI 1275709941
$202,297.26
in general payments reported to CMS, 2019-2025
17 companies · $126K in 2025
The $126K reported for 2025 was more than what 99% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,248 · 2020: $555 · 2021: $1,698 · 2022: $9,180 · 2023: $22K · 2024: $38K · 2025: $126K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $96K · Travel and Lodging: $55K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,306 · Honoraria: $1,750 · Education: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $95,874.22 |
| Travel and Lodging | $55,095.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,894.50 |
| Food and Beverage | $11,687.95 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,306.25 |
| Honoraria | $1,750.00 |
| Education | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $125,597.74 | 2019-2025 | Amplatzer Amulet, Tacticath Ablation Catheter, Sensor Enabled, Jeti All In One Non-Sterile Kit |
| Biosense Webster, INC. | $27,162.85 | 2019-2025 | Carto 3 |
| Pulse Biosciences, INC. | $14,415.21 | 2025 | Cellfx |
| Sanofi-Aventis U.S. LLC | $12,475.29 | 2022-2023 | |
| Boston Scientific Corporation | $10,371.00 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, Resonate El Icd Vr |
| Medtronic, INC. | $6,051.39 | 2021-2025 | Onyx Frontier, Micra, Cobalt Dr Mri Surescan |
| Altathera Pharmaceuticals LLC | $4,482.17 | 2023-2025 | Sotalol Hydrochloride |
| W. L. Gore & Associates, INC. | $642.00 | 2025 | Product In Development |
| Baylis Medical Company INC | $352.30 | 2019 | |
| Biotronik INC. | $150.32 | 2024 | Orsiro Mission |
| E.R. Squibb & Sons, L.L.C. | $134.35 | 2022-2023 | Camzyos |
| Medtronic Vascular, INC. | $123.06 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $99.69 | 2019-2023 | Xarelto |
| Cardiva Medical, INC. | $75.16 | 2021-2023 | Cardiva Vascade 5f Vcs |
| Acutus Medical, INC. | $70.49 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.20 | 2019 | |
| Atricure, INC. | $47.04 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohit Turagam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.